Progressive Clinical Research

Futó vizsgálatok

• Fut, nem toboroz

  A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

  NCT07230860· 2. fázis· Forrás

• Fut, nem toboroz

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

  NCT06934226· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

  NCT06611163· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  NCT06143878· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

  NCT06095102· 3. fázis· Forrás

• Fut, nem toboroz

  Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

  NCT05509023· 2. fázis· Forrás

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

  NCT07150845· 2. fázis· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

  NCT06921759· 3. fázis· Forrás

• Lezárult

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

  NCT06588283· 3. fázis· Forrás

• Lezárult

  Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

  NCT06039189· 3. fázis· Forrás

• Visszavonták

  Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

  NCT05233410· 3. fázis· Forrás

• Visszavonták

  Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1

  NCT05219864· 3. fázis· Forrás

• Lezárult

  A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

  NCT05372419· 3. fázis· Forrás

• Lezárult

  Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

  NCT05456529· 3. fázis· Forrás

• Lezárult

  Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

  NCT05272150· 3. fázis· Forrás

• Leállították

  An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

  NCT05399368· 2. fázis· Forrás

• Lezárult

  A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

  NCT04921969· 3. fázis· Forrás

• Lezárult

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· 3. fázis· Forrás